Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Preventative Angioplasty Reduces Mortality Risk after Heart Attack

By HospiMedica International staff writers
Posted on 10 Sep 2019
Complete multivessel revascularization following a ST-segment elevation myocardial infarction (STEMI) reduces the risk of cardiovascular death, according to a new study.

Researchers at McMaster University (Hamilton, ON, Canada), Instituto Dante Pazzanese de Cardiologia (São Paulo, Brazil), and an additional 128 hospitals in 31 countries randomly assigned 4,131 patients with STEMI and multivessel coronary artery disease (CAD) who underwent successful culprit-lesion PCI to a strategy of either complete revascularization with percutaneous coronary intervention (PCI) of all angiographically significant nonculprit lesions (2,106 patients), or no further revascularization (2,025 controls). More...
The main outcome was the composite of cardiovascular death or MI.

The results at median three year follow-up showed that 7.8% of patients in the total revascularization group suffered the main outcome, compared with 10.5% in the control, culprit-lesion only PCI group. When taking into account ischemia-driven revascularization, the difference was even greater, at 8.9% in the complete revascularization group, compared to 16.7% in the culprit-lesion-only controls. The benefit of complete revascularization was consistently observed, regardless of the intended timing of nonculprit lesion PCI. The study was published on September 1, 2019, in the New England Journal of Medicine (NEJM).

“Although it had been known that opening of the single blocked artery that caused the heart attack with stents was beneficial, it was unclear whether additional stents to clear the other clogged arteries further prevented death or heart attack,” said lead author Shamir Mehta, MD, of McMaster University. “In most cases, doctors would just treat the additional blockages with medication alone. This study clearly showed that there is long-term benefit in preventing serious heart-related events by clearing all of the arteries. There was also no major downside to the additional procedures.”

PCI (formerly known as angioplasty with stent) is a non-surgical procedure that accesses the coronary vessels through the femoral or radial artery using a catheter and fluoroscopy to access atherosclerotic plaque obstructions. An interventional cardiologist can then perform an angioplasty, using a balloon catheter to inflate to relieve the narrowing; in many case, a stent is deployed to keep the blood vessel open. Various other procedures can also be performed.

Related Links:
McMaster University
Instituto Dante Pazzanese de Cardiologia


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.